PPA
BEAM icon

Parametric Portfolio Associates’s Beam Therapeutics BEAM Stock Holding History

Parametric Portfolio Associates’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$841K Sell
14,684
-7,552
-34% -$495K ﹤0.01% 2855
2021
Q4 		$1.77M Sell
22,236
-2,333
-9% -$200K ﹤0.01% 2506
2021
Q3 		$2.14M Buy
24,569
+3,520
+17% +$354K ﹤0.01% 2410
2021
Q2 		$2.71M Buy
21,049
+3,985
+23% +$318K ﹤0.01% 2265
2021
Q1 		$1.37M Sell
17,064
-11,751
-41% -$1.12M ﹤0.01% 3007
2020
Q4 		$2.35M Buy
+28,815
New +$1.42M ﹤0.01% 2559

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's BEAM Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Beam Therapeutics (BEAM) stake by 34% in Q1 2022, selling an estimated $495K and leaving 14,684 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

Parametric Portfolio Associates first reported a position in BEAM in Q4 2020 and has held it in 6 quarters since. The position peaked at $2.71M in Q2 2021. 240 funds tracked by Wall St. Rank hold BEAM as of Q1 2022.

  • Parametric Portfolio Associates held 14,684 shares of Beam Therapeutics worth $841K as of Q1 2022.
  • Parametric Portfolio Associates sold 7,552 Beam Therapeutics shares in Q1 2022, an estimated $495K.
  • Beam Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2855 holding.
  • Parametric Portfolio Associates first reported a position in Beam Therapeutics in Q4 2020 and has held it in 6 quarters since.
  • Parametric Portfolio Associates's Beam Therapeutics position peaked at $2.71M in Q2 2021.
  • 240 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.